Evidence map›Paper›PMID 40036335›Full record

ArticleNucleic acids research2025

ProQ prevents mRNA degradation through inhibition of poly(A) polymerase.

Sofia Bergman, Christopher Birk, Erik Holmqvist

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. What makes a small RNA work?Nucleic acids research · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sofia BergmanDepartment of Cell and Molecular Biology, Biomedical Centre, Uppsala University, 75124 Uppsala, Sweden.
Christopher Birk
Erik HolmqvistDepartment of Cell and Molecular Biology, Biomedical Centre, Uppsala University, 75124 Uppsala, Sweden.ORCID 0000-0001-7834-1487

Funding

Swedish Foundation for Strategic Research ICA16-0021Swedish Research Council 2016-03656
6 · The paper itself

Abstract

The RNA-binding protein ProQ interacts with many transcripts in the bacterial cell. ProQ binding is associated with increased messenger RNA (mRNA) levels, but a mechanistic explanation for this effect has been lacking. In Salmonella Typhimurium, ProQ affects key traits associated with infection, including motility and intracellular survival. However, the direct links between ProQ activity and these phenotypes are not well understood. Here, we demonstrate that ProQ promotes biofilm formation, another virulence-associated phenotype. This effect is strictly dependent on sigma factor RpoS. ProQ increases both RpoS protein and rpoS mRNA levels, but neither affects rpoS transcription nor translation. The rpoS mRNA is a ProQ target, and expression of the rpoS 3'UTR alone is strongly dependent on ProQ. RpoS expression becomes independent of ProQ in strains lacking poly(A) polymerase I (PAPI), indicating that ProQ protects against 3' end-dependent decay. Indeed, purified ProQ inhibits PAPI-mediated polyadenylation at RNA 3' ends. Finally, PAPI is required for ProQ's effect on expression of genes involved in biofilm, motility, osmotic stress, and virulence, indicating that inhibition of polyadenylation is a general function of ProQ.

Indexed as

Bacterial ProteinsPolynucleotide AdenylyltransferaseRNA-Binding ProteinsRNA, MessengerRNA StabilitySalmonella typhimurium3' Untranslated RegionsBiofilmsGene Expression Regulation, BacterialPolyadenylationSigma FactorVirulence3' Untranslated RegionsBacterial ProteinsPolynucleotide AdenylyltransferaseRNA-Binding ProteinsRNA, MessengerSigma Factorsigma factor KatF protein, Bacteria

Identifiers

PMID40036335
PMCPMC12086684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.